original ) (raw )The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody Positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository
Maria Efthymiou
Arthritis care & research, 2018
View PDFchevron_right
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository
Guilherme De Jesus
Arthritis Care and Research, 2018
View PDFchevron_right
The spectrum between antiphospholipid syndrome and systemic lupus erythematosus
Nancy Agmon-Levin
Clinical Rheumatology, 2014
View PDFchevron_right
Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Francesca Pregnolato
Current Opinion in Rheumatology, 2009
View PDFchevron_right
Extended antiphospholipid antibodies screening in systemic lupus erythematosus patients
Alina Dima
Romanian Journal Of Internal Medicine, 2015
View PDFchevron_right
Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE
Manuel Saavedra Bustamante
2009
View PDFchevron_right
Secondary antiphospholipid syndrome in systemic lupus erythematosus – screening, diagnosis and treatment methods
Diana Mazilu
Romanian Journal of Rheumatology
View PDFchevron_right
Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus
Mónica Zuluaga Quintero
Clinical Rheumatology, 2017
View PDFchevron_right
Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement?
Francesca Pregnolato
Neurological Sciences, 2009
View PDFchevron_right
Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
Alberto Calligaro
Annals of the Rheumatic Diseases, 1994
View PDFchevron_right
Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus
Marcus Maurer
British Journal of Dermatology, 2013
View PDFchevron_right
Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?
Milena Hasan
Autoimmunity reviews, 2018
View PDFchevron_right
Antiphospholipid Syndrome in Systemic Lupus Erythematosus
marta michowska
Journal of the American Society of Nephrology, 2007
View PDFchevron_right
Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes
Desmond Y H Yap
Lupus, 2019
View PDFchevron_right
Antiphospholipid Syndrome in Systemic Lupus Erythematosus: Is the Whole Greater Than the Sum of Its Parts?
Carl LASKIN
Rheumatic Disease Clinics of North America, 2005
View PDFchevron_right
Significance of anti-phospholipid antibodies in patients with lupus nephritis
John Stewart Cameron
Kidney International, 1991
View PDFchevron_right
Antiphospholipid Antibodies and Their Association with Atherosclerotic Changes in Patients with Systemic Lupus Erythematosus – Review of Literature and Own Experiences
Katarzyna Fischer , Marek Brzosko
Antiphospholipid Syndrome, 2012
View PDFchevron_right
Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study
Maria Longu , Gian Erre , Giuseppe Passiu
Rheumatology international, 2014
View PDFchevron_right
The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians
Adriana Rojas-Villarraga
PLoS ONE, 2014
View PDFchevron_right
Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities
D. Roccatello
Journal of Thrombosis and Haemostasis, 2012
View PDFchevron_right
Prevalence and clinical correlates of anti‐phospholipid antibodies in South Africans with systemic lupus erythematosus
Trevor Gould
Scandinavian Journal of Rheumatology, 2006
View PDFchevron_right
OP0124 DO All Antiphospholipid Antibodies Confer the Same Risk for Major Organ Involvement in Sle Patients?
Enrique Raya
Annals of the Rheumatic Diseases, 2019
View PDFchevron_right
Antiphospholipid Antibodies and the Antiphospholipid Syndrome
Ricard Cervera , P. Meroni
Annals of the New York Academy of Sciences, 1997
View PDFchevron_right
Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus
Daniel Santiago Trujillo Ruiz
The American Journal of the Medical Sciences, 2017
View PDFchevron_right
A Comparison of Lupus Anticoagulant Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those Without
Vittorio Pengo , P. Gresele
Arteriosclerosis Thrombosis and Vascular Biology, 2007
View PDFchevron_right
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
Emese Kiss
Annals of the Rheumatic Diseases, 2014
View PDFchevron_right
Cardiovascular disease in the antiphospholipid syndrome
Adriana Rojas-Villarraga
Lupus, 2014
View PDFchevron_right
Prevalence and Clinical Correlation of Anti-PhospholipidBinding Protein Antibodies in Anticardiolipin-Negative Patients With Systemic Lupus Erythematosus and …
Marilina Tampoia
2009
View PDFchevron_right
Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome
Joan Carles Reverter
Rheumatology, 2005
View PDFchevron_right
Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
annamaria scotta
Frontiers in Immunology, 2019
View PDFchevron_right